Medical Director​/Senior Medical Director, Clinical Development

Medical Director/Senior Medical Director, Clinical Development

Tenvie Therapeutic sis developing precision‑engineered small molecule therapies to address core drivers of neurological and peripheral diseases: neuroinflammation and cellular dysfunction. Leveraging its proprietary product engine,Tenviehas the unique ability to advance both fully CNS‑penetrant and peripherally restricted products across a broad portfolio.

Tenvie’smost advanced programs, TNV
262 and TNV
108,are in Phase 1 clinical development.

TNV
262isa fully CNS-penetrant NLRP3 inhibitor targeting cardiometabolicand neuroinflammatoryindications, including obesityandcardiovascular disease,and multiple sclerosis.

TNV
108isa peripherally restricted SARM1 allosteric inhibitor targeting peripheral neuropathies.

Tenvie’sclinical pipeline is complemented by discovery-stage programs across a range of related indications.

Tenvie Therapeutics is seeking a Medical Director to lead early- and mid-stage clinical programs across multiple indications including cardiometabolic and neurologic diseases. This physician leader will drive successful clinical trial execution, provide medical oversight, and support regulatory submissions partnering closely with cross-functional colleagues to advance differentiated therapies for patients with high unmet medical need. This role can be remote, hybrid, or on-site, and reports within the Clinical Development group.

• Provide medical leadership for key studies
  • Serve asglobal medical leadfor assigned studies/programs, providing medical and scientific leadership to cross‑functional teams
  • Lead the design of Phase 1–2 trials (and contribute to Phase 3 planning), including objectives, endpoints, inclusion/exclusion criteria, and risk–benefit considerations
  • Chair or co‑chair safety review / dose‑escalation committees, ensuring timely, balanced dose decisions grounded in safety and PK/PD data
• Ensure high‑quality clinical and regulatory documentation
  • Lead or oversee authoring of clinical components of protocols, IBs, ICFs, CSRs, pediatric plans, and other key documents
  • Author clinical sections of regulatory submissions(e.g., IND/CTA, briefing packages, responses to health authorities) and participate in FDA/EMA and other agency interactions
  • Partner with Biostatistics, Clinical Pharmacology, and Translational Science on endpoint hierarchy, statistical analysis plans, and biomarker strategies
• Provide ongoing medical oversight and safety leadership
  • Oversee medical monitoring, including eligibility reviews, safety signal monitoring, and protocol deviations
  • Collaborate with Pharmacovigilance on safety evaluation, signal detection, and risk mitigation strategies
  • Lead or contribute to Safety Review Committees/Data Monitoring Committees, including review of safety narratives and serious adverse events
• Drive data interpretation and communication
  • Lead integrated interpretation of efficacy, safety, PK/PD, and biomarker datafor internal decision‑making and external communication
  • Prepare and deliver presentations to internal governance, board‑level committees as appropriate, and external stakeholders
  • Oversee or contribute to abstracts, posters, and manuscripts for major scientific and medical congresses and peer‑reviewed journals
• Engage with investigators, KOLs, and external partners
  • Build and maintain strong relationships with investigators and KOLs
  • Lead or co‑lead advisory boards and scientific consultations, ensuring external insights are incorporated into program strategy and study design
  • Collaborate with CROs and other vendors to ensure alignment on medical/scientific expectations and quality
• Contribute to portfolio and organizational excellence
  • Help shape clinical development best practices, templates, and processes across the…